Skip to content
Sign inOpen the app
Pharmaceutical Executive

Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration

July 28 · 10 min · 10.1 MB
0:00-10:30

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod

In today's Pharmaceutical Executive Daily, BioMarin and n-Lorem Foundation partner on the first disease-targeted therapy for the recently identified ReNU syndrome, a trio of biotech financings advance rare disease, sleep apnea, and oncology pipelines, and a Wharton professor offers career advice for MBA graduates navigating an AI-reshaped job market.